Corporate News 09-Feb-17
Ajanta Pharma provides update on USFDA inspection
At its Paithan facility
Ajanta Pharma announced that the Company's Paithan facility was recently inspected by US FDA and the Company has issued one procedural related 483. The Company is in process of responding to the same within the stipulated time prescribed by US FDA.
Previous News
Ajanta Pharma fixes record date for 2nd interim dividend
( Market Beat - Reports 31-Jan-24 17:37 )
Volumes jump at Ajanta Pharma Ltd counter
( Hot Pursuit - 03-May-24 11:00 )
Indices pare all early gains; metal shares rally for 2nd day
( Market Commentary - Mid-Session 03-May-24 10:36 )
Ajanta Pharma consolidated net profit rises 56.14% in the December 2023 quarter
( Results - Announcements 31-Jan-24 18:04 )
Board of Ajanta Pharma recommends Second Interim Dividend
( Corporate News - 31-Jan-24 17:15 )
Volumes spurt at Ajanta Pharma Ltd counter
( Hot Pursuit - 03-May-24 14:30 )
Ajanta Pharma board OKs Rs 315-cr share buyback
( Hot Pursuit - 10-Mar-23 11:54 )
Ajanta Pharma
( Results - Analysis 06-May-23 21:31 )
Ajanta Pharma standalone net profit declines 22.27% in the June 2022 quarter
( Results - Announcements 28-Jul-22 17:16 )
Sensex tanks 909 pts; European mkt opens higher
( Market Commentary - Mid-Session 03-May-24 13:42 )
Ajanta Pharma slips after US FDA issues form 483 to Dahej facility
( Hot Pursuit - 12-Sep-22 11:59 )
Other Stories
Vardhan Capital & Finance schedules AGM
06-Jul-24 17:34
Automotive Axles schedules AGM
06-Jul-24 17:34
Maruti Infrastructure to conduct AGM
06-Jul-24 17:34
Torrent Power schedules AGM
06-Jul-24 17:34
Raghav Productivity Enhancers to hold AGM
06-Jul-24 17:34
Berger Paints India schedules AGM
06-Jul-24 17:33
Walpar Nutritions to conduct AGM
06-Jul-24 17:33
Weizmann AGM scheduled
06-Jul-24 17:33
Gretex Industries schedules AGM
06-Jul-24 17:33
Karma Energy schedules AGM
06-Jul-24 17:33
Back
Top
